NasdaqGS:OPCHHealthcare
How Option Care Health's Strategic Moves at Jefferies Conference (OPCH) Have Changed Its Investment Story
Option Care Health recently outlined its strategic plans at the Jefferies London Healthcare Conference, responding to a US$60 million to US$70 million anticipated revenue headwind in 2025 from Stelara biosimilar discount adjustments, while raising its full-year outlook and forecasting growth in key financial metrics for 2026.
Despite addressing near-term revenue challenges, the company's continued expansion of its advanced practitioner model and commitment to share buybacks signal a focus on...